Ocugen (NASDAQ: OCGN) revenue
Ocugen reported revenue of $4.4m for fiscal 2025, 8.8% more than in fiscal 2024 ($4.1m).
Ocugen's best year of the last 10 was fiscal 2023. The biggest drop was in fiscal 2024, −32.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $4.4m | +8.8% | −$62.9m | −1,425.7% |
| 2024 | $4.1m | −32.8% | −$54.8m | −1,350.4% |
| 2023 | $6.0m | +142.6% | −$65.5m | −1,085.7% |
| 2022 | $2.5m | — | −$89.1m | −3,580.0% |
| 2021 | $0.0m | −100.0% | −$58.0m | — |
| 2020 | $0.0m | — | −$21.3m | −49,500.0% |
| 2019 | $0.0m | — | −$14.2m | — |
| 2018 | $0.0m | — | −$16.1m | — |
| 2017 | $0.0m | — | −$25.0m | — |
| 2016 | $0.0m | — | −$30.3m | — |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Ocugen revenue compared with its sector
By revenue for its latest fiscal year, Ocugen ranks 383rd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Ocugen, 8.8%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 381st | Lucid Diagnostics | $4.7m | 8.3% |
| 382nd | Prime Medicine | $4.6m | 55.3% |
| 383rd | Ocugen | $4.4m | 8.8% |
| 384th | CG Oncology | $4.0m | 254.7% |
| 385th | Crispr Therapeutics AG | $3.5m | −90.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Ocugen
- How much revenue did Ocugen make in fiscal 2025?
- Ocugen reported revenue of $4.4m for fiscal 2025, compared with $4.1m in fiscal 2024.
- What was the best year for revenue at Ocugen?
- Of its last 10 fiscal years, fiscal 2023, with $6.0m.
- Where does Ocugen rank in its sector by revenue?
- It ranks 383rd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Ocugen come from?
- From the annual report (Form 10-K) that Ocugen files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Ocugen files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Ocugen: the Ocugen page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.